Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy and Stem Cell Transplant in Multiple Myeloma and Amyloidosis
NCT00007995Phase 2Completed
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Jul 1999
- Primary completion
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan, busulfan, cyclophosphamide in multiple myeloma (MM), primary systemic amyloidosis, sponsored by Herbert Irving Comprehensive Cancer Center. Started Jul 1999; status: completed.
02
Drugs
melphalanbusulfancyclophosphamide
03
Conditions
multiple myeloma (MM)primary systemic amyloidosis
Beyond the preview
Go deeper on NCT00007995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007995.